港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

晶泰控股

9.800

+0.5806.29%

成交量：3,525.80万

成交额：3.42亿

市值：421.69亿

市盈率：-11.27

高：9.850

开：9.300

低：9.300

收：9.220

52周最高：15.120

52周最低：3.850

股本：43.03亿

香港流通股本：43.03亿

量比：5.75

换手率：0.82%

股息：- -

股息率：- -

每股收益(LYR):-0.869

净资产收益率：-3.61%

总资产收益率：-3.35%

市净率：5.45

市盈率(LYR):-11.27

市销率: 55.99

数据加载中...

总览公司新闻资讯公告

晶泰控股09月11日主力净流入162.4万元散户资金抛售

70家创新药上市公司 3家靠自身造血盈利

经济观察网

国家卫健委：我国跃居全球新药研发第二位

川普制裁中国创新药？别被纽约时报的“小作文”忽悠了

越学习越贫穷

海外云厂商指引爆表！美若降息港股反弹程度如何？

汇添富基金

创新药中场复盘：泡沫挤压后的新起点

Ofweek维科网

晶泰控股(2228.HK)：AI+人工智能自主实验平台驱动药物及材料研发商业化加速

晶泰控股AI药物发现合作达成重要里程碑：Pharmaengine新型Prmt5抑制剂Pep08获得临床试验批准

晶泰控股等在上海新设生物科技公司

每日卖空追踪 | 晶泰控股 09月08日卖空量成交591.9万股，卖空比例为3.63%

晶泰科技(02228)助力智擎生技新一代“合成致死”新药获临床实验审批 AI制药再迎里程碑

医药生物行业跟踪周报：政策支持与技术迸发叠加看好脑机接口产业链发展建议关注诚益通、三博脑科等

异动解读 | AI药物研发龙头晶泰控股盘中大涨8.09%，南向资金连续7日增持

晶泰科技到广药集团调研交流，共商合作新机遇

白云山官微

晶泰控股完成配售2.86亿股净筹26.3亿港元加速业务扩张与研发投入

格隆汇资讯

晶泰控股(02228.HK)完成配售合共2.859亿股新股份

每日卖空追踪 | 晶泰控股 09月04日卖空量成交314.2万股，卖空比例为1.98%

晶泰控股盘中异动下午盘大幅下挫5.08%

医药行业细分龙头+医药政策频出，该公司有望再爆发！

每日卖空追踪 | 晶泰控股 09月02日卖空量成交1132.8万股，卖空比例为6.12%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02228/news?page=9"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02228","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02228\",,,,,undefined,":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股","latestPrice":9.8,"timestamp":1766110506554,"preClose":9.22,"halted":0,"volume":35258000,"delay":0,"floatShares":4303000000,"shares":4303000000,"eps":-0.8694304107041421,"marketStatus":"交易中","change":0.58,"latestTime":"12-19 10:15:09","open":9.3,"high":9.85,"low":9.3,"amount":341892951,"amplitude":0.059653,"askPrice":9.8,"askSize":41000,"bidPrice":9.79,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":-0.06726367190357245,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1766116800000},"marketStatusCode":2,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":9.22,"openAndCloseTimeList":[[1766107800000,1766116800000],[1766120400000,1766131200000]],"volumeRatio":5.752592,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02228\",,,,,undefined,":{"symbol":"02228","floatShares":4303000000,"roa":"-3.35%","roe":"-3.61%","lyrEps":-0.86943,"volumeRatio":5.752592,"shares":4303000000,"dividePrice":0,"high":9.85,"amplitude":0.059653,"preClose":9.22,"low":9.3,"week52Low":3.85,"pbRate":"5.45","psRate":"55.99","week52High":15.12,"institutionHeld":0,"latestPrice":9.8,"committee":-0.822222,"eps":-0.8694304107041421,"divideRate":0,"volume":35258000,"delay":0,"ttmEps":-0.06726367190357245,"open":9.3,"prevYearClose":5.98,"prevWeekClose":9.5,"prevMonthClose":10.01,"prevQuarterClose":14.22,"fiveDayClose":9.5,"twentyDayClose":9.67,"sixtyDayClose":11.69},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02228\",params:#limit:5,,,undefined,":[{"date":"2025-08-27","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756258200000,"name":null,"time":"","dateTimestamp":1756224000000,"actualEps":null},{"date":"2025-03-28","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-28","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02228\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02228\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1760284800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02228\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02228","date":"2025-12-18","current":-138.252498,"percent":0.199468,"low":-297.4207,"twenty":-182.258679,"median":-10.270117,"eighty":-8.144723,"high":-4.071689,"avg":-52.601863,"sd":84.782168,"marketCap":39675013136},"quantilePoints":[{"date":"2024-06-14","current":-8.922014,"twenty":-9.439723,"median":-9.245582,"eighty":-9.051441,"marketCap":18396572909},{"date":"2024-06-21","current":-8.857946,"twenty":-8.9092,"median":-8.775161,"eighty":-8.737522,"marketCap":18226234271},{"date":"2024-06-28","current":-8.745676,"twenty":-8.918198,"median":-8.816527,"eighty":-8.750223,"marketCap":17987760178},{"date":"2024-07-05","current":-8.747576,"twenty":-8.902934,"median":-8.771787,"eighty":-8.744343,"marketCap":17987760178},{"date":"2024-07-12","current":-9.049063,"twenty":-8.902934,"median":-8.775161,"eighty":-8.741587,"marketCap":18635047002},{"date":"2024-07-19","current":-9.247407,"twenty":-9.172529,"median":-8.857489,"eighty":-8.744343,"marketCap":19043859733},{"date":"2024-07-26","current":-9.575773,"twenty":-9.510189,"median":-8.892407,"eighty":-8.745676,"marketCap":19793349741},{"date":"2024-08-02","current":-9.235042,"twenty":-9.509847,"median":-8.912474,"eighty":-8.745676,"marketCap":19077927461},{"date":"2024-08-09","current":-9.468775,"twenty":-9.510189,"median":-8.974725,"eighty":-8.747576,"marketCap":19691146558},{"date":"2024-08-16","current":-10.464009,"twenty":-9.56947,"median":-9.142341,"eighty":-8.760904,"marketCap":21769277942},{"date":"2024-08-23","current":-10.517808,"twenty":-9.632925,"median":-9.235042,"eighty":-8.768412,"marketCap":21973684308},{"date":"2024-08-30","current":-10.371399,"twenty":-10.303269,"median":-9.325095,"eighty":-8.775161,"marketCap":28923500740},{"date":"2024-09-06","current":-18.461728,"twenty":-10.496901,"median":-9.468775,"eighty":-8.776023,"marketCap":51510404146},{"date":"2024-09-13","current":-17.236995,"twenty":-10.891661,"median":-9.521964,"eighty":-8.857032,"marketCap":47967360474},{"date":"2024-09-20","current":-16.063353,"twenty":-11.51195,"median":-9.559061,"eighty":-8.857763,"marketCap":44969400445},{"date":"2024-09-27","current":-15.483466,"twenty":-14.686278,"median":-9.575773,"eighty":-8.860072,"marketCap":43606691340},{"date":"2024-10-04","current":-13.755671,"twenty":-14.947547,"median":-9.615329,"eighty":-8.879685,"marketCap":38564667654},{"date":"2024-10-10","current":-12.348216,"twenty":-14.780027,"median":-9.846626,"eighty":-8.896618,"marketCap":34408404886},{"date":"2024-10-18","current":-11.446606,"twenty":-14.586898,"median":-10.272952,"eighty":-8.910566,"marketCap":31717054404},{"date":"2024-10-25","current":-12.086709,"twenty":-14.247622,"median":-10.371399,"eighty":-8.935918,"marketCap":33488576240},{"date":"2024-11-01","current":-11.046421,"twenty":-13.547793,"median":-10.507354,"eighty":-8.963954,"marketCap":30626887121},{"date":"2024-11-08","current":-8.233542,"twenty":-13.084166,"median":-10.464009,"eighty":-8.959678,"marketCap":22655038860},{"date":"2024-11-15","current":-6.674421,"twenty":-12.818197,"median":-10.331022,"eighty":-8.873325,"marketCap":18226234271},{"date":"2024-11-22","current":-5.092957,"twenty":-12.605094,"median":-9.956054,"eighty":-8.775506,"marketCap":13899632864},{"date":"2024-11-29","current":-4.071689,"twenty":-12.362191,"median":-9.633447,"eighty":-8.746436,"marketCap":11106079200},{"date":"2024-12-06","current":-6.234627,"twenty":-12.309524,"median":-9.607633,"eighty":-8.729287,"marketCap":16965728349},{"date":"2024-12-13","current":-4.937116,"twenty":-12.241743,"median":-9.572622,"eighty":-8.309283,"marketCap":13422684678},{"date":"2024-12-20","current":-6.992956,"twenty":-12.176011,"median":-9.548971,"eighty":-7.374004,"marketCap":18907588823},{"date":"2024-12-27","current":-7.61626,"twenty":-12.099333,"median":-9.521964,"eighty":-6.992956,"marketCap":20576907476},{"date":"2025-01-03","current":-6.613619,"twenty":-12.089234,"median":-9.489311,"eighty":-6.978437,"marketCap":17885556995},{"date":"2025-01-10","current":-5.450117,"twenty":-12.058756,"median":-9.391379,"eighty":-6.644107,"marketCap":14683190599},{"date":"2025-01-17","current":-5.875315,"twenty":-12.04248,"median":-9.241225,"eighty":-6.25569,"marketCap":15841493338},{"date":"2025-01-24","current":-6.177753,"twenty":-11.949888,"median":-9.172529,"eighty":-6.11967,"marketCap":16761321984},{"date":"2025-01-28","current":-6.498305,"twenty":-11.921589,"median":-9.112153,"eighty":-6.130311,"marketCap":17715218357},{"date":"2025-02-07","current":-7.424154,"twenty":-11.872333,"median":-8.96938,"eighty":-6.148709,"marketCap":20134027017},{"date":"2025-02-14","current":-8.323374,"twenty":-11.760531,"median":-8.922014,"eighty":-6.178085,"marketCap":22518767950},{"date":"2025-02-21","current":-10.607329,"twenty":-11.720414,"median":-8.939394,"eighty":-6.187416,"marketCap":28855365285},{"date":"2025-02-28","current":-8.380735,"twenty":-11.643652,"median":-8.964036,"eighty":-6.222464,"marketCap":22723174315},{"date":"2025-03-07","current":-8.409794,"twenty":-11.556185,"median":-8.912474,"eighty":-6.239893,"marketCap":22893512953},{"date":"2025-03-14","current":-8.131514,"twenty":-11.5122,"median":-8.860603,"eighty":-6.269085,"marketCap":22144022946},{"date":"2025-03-21","current":-7.997044,"twenty":-11.440339,"median":-8.816527,"eighty":-6.340941,"marketCap":21769277942},{"date":"2025-03-28","current":-9.307254,"twenty":-11.391935,"median":-8.776023,"eighty":-6.503525,"marketCap":25284615976},{"date":"2025-04-03","current":-13.220486,"twenty":-11.563082,"median":-8.857032,"eighty":-6.524404,"marketCap":21465794803},{"date":"2025-04-11","current":-11.616184,"twenty":-11.563082,"median":-8.876505,"eighty":-6.613619,"marketCap":18692124688},{"date":"2025-04-17","current":-8.481901,"twenty":-11.535495,"median":-8.876505,"eighty":-6.644107,"marketCap":18290143512},{"date":"2025-04-25","current":-9.200975,"twenty":-11.479403,"median":-8.897671,"eighty":-6.665344,"marketCap":19857870099},{"date":"2025-05-02","current":-9.49742,"twenty":-11.434072,"median":-8.939394,"eighty":-6.691701,"marketCap":20541238098},{"date":"2025-05-09","current":-8.545306,"twenty":-11.391935,"median":-8.912474,"eighty":-6.740034,"marketCap":18611728453},{"date":"2025-05-16","current":-7.908546,"twenty":-11.248155,"median":-8.860603,"eighty":-6.84782,"marketCap":17365586807},{"date":"2025-05-23","current":-8.341266,"twenty":-11.042865,"median":-8.857489,"eighty":-6.934878,"marketCap":18370539747},{"date":"2025-05-30","current":-8.359272,"twenty":-11.017454,"median":-8.801107,"eighty":-7.008251,"marketCap":18491134100},{"date":"2025-06-06","current":-8.60989,"twenty":-10.956499,"median":-8.771787,"eighty":-7.088154,"marketCap":19094105864},{"date":"2025-06-13","current":-11.034423,"twenty":-11.017454,"median":-8.801107,"eighty":-7.190725,"marketCap":24480653624},{"date":"2025-06-20","current":-10.674849,"twenty":-11.017454,"median":-8.857489,"eighty":-7.306284,"marketCap":23636493154},{"date":"2025-06-27","current":-10.445897,"twenty":-10.956499,"median":-8.892407,"eighty":-7.344497,"marketCap":23194313860},{"date":"2025-07-04","current":-9.829906,"twenty":-10.891661,"median":-8.922014,"eighty":-7.419935,"marketCap":21827577862},{"date":"2025-07-11","current":-10.057272,"twenty":-10.877908,"median":-8.960404,"eighty":-7.424154,"marketCap":22309955273},{"date":"2025-07-18","current":-11.044472,"twenty":-10.891661,"median":-8.991768,"eighty":-7.446553,"marketCap":24480653624},{"date":"2025-07-25","current":-11.600754,"twenty":-10.891661,"median":-9.041584,"eighty":-7.524651,"marketCap":25807191505},{"date":"2025-08-01","current":-10.363772,"twenty":-11.018326,"median":-9.112153,"eighty":-7.542967,"marketCap":22912927037},{"date":"2025-08-08","current":-12.886171,"twenty":-11.034423,"median":-9.184965,"eighty":-7.546272,"marketCap":28560882520},{"date":"2025-08-15","current":-16.789867,"twenty":-11.214642,"median":-9.213525,"eighty":-7.606542,"marketCap":37157266289},{"date":"2025-08-22","current":-18.517848,"twenty":-11.446606,"median":-9.246727,"eighty":-7.614904,"marketCap":40852907909},{"date":"2025-08-29","current":-192.489316,"twenty":-11.600754,"median":-9.307254,"eighty":-7.61626,"marketCap":41415288155},{"date":"2025-09-05","current":-213.80174,"twenty":-11.767021,"median":-9.420728,"eighty":-7.685893,"marketCap":45955204407},{"date":"2025-09-12","current":-204.225419,"twenty":-12.040158,"median":-9.491689,"eighty":-7.778357,"marketCap":43975860397},{"date":"2025-09-19","current":-210.969495,"twenty":-12.227129,"median":-9.510018,"eighty":-7.835319,"marketCap":45395824578},{"date":"2025-09-26","current":-243.797394,"twenty":-12.760818,"median":-9.548971,"eighty":-7.865608,"marketCap":52323528613},{"date":"2025-10-03","current":-292.020324,"twenty":-13.170522,"median":-9.56947,"eighty":-7.879637,"marketCap":62822657710},{"date":"2025-10-10","current":-230.752283,"twenty":-13.473827,"median":-9.584146,"eighty":-7.898385,"marketCap":49569658686},{"date":"2025-10-17","current":-224.517278,"twenty":-14.439918,"median":-9.600107,"eighty":-7.946472,"marketCap":48192723723},{"date":"2025-10-24","current":-228.64383,"twenty":-14.683263,"median":-9.632925,"eighty":-7.976689,"marketCap":49096337293},{"date":"2025-10-31","current":-227.302855,"twenty":-15.037482,"median":-9.687573,"eighty":-7.986804,"marketCap":48881191204},{"date":"2025-11-07","current":-224.641911,"twenty":-15.538461,"median":-9.759922,"eighty":-8.024089,"marketCap":48278782158},{"date":"2025-11-14","current":-224.606105,"twenty":-15.942578,"median":-9.829906,"eighty":-8.077422,"marketCap":48407869811},{"date":"2025-11-21","current":-193.151407,"twenty":-16.49847,"median":-9.886762,"eighty":-8.100259,"marketCap":41609253428},{"date":"2025-11-28","current":-199.219037,"twenty":-17.166208,"median":-9.938523,"eighty":-8.106838,"marketCap":43072246827},{"date":"2025-12-05","current":-187.760939,"twenty":-18.514915,"median":-10.001834,"eighty":-8.117649,"marketCap":40664736891},{"date":"2025-12-12","current":-188.405895,"twenty":-19.068562,"median":-10.222616,"eighty":-8.135742,"marketCap":40879894229},{"date":"2025-12-18","current":-182.422952,"twenty":-182.258679,"median":-10.270117,"eighty":-8.144723,"marketCap":39675013136}],"updateTime":1766107003513},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02228\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2566957475","title":"晶泰控股09月11日主力净流入162.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2566957475","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566957475?lang=zh_cn&edition=fundamental","pubTime":"2025-09-11 16:15","pubTimestamp":1757578506,"startTime":"0","endTime":"0","summary":"09月11日, 晶泰控股股价涨1.89%，报收10.22元，成交金额16.8亿元，换手率3.94%，振幅8.18%，量比1.03。晶泰控股今日主力资金净流入162.4万元，上一交易日主力净流出6086.1万元。该股近5个交易日上涨7.35%，主力资金累计净流入2.8亿元；近20日主力资金累计净流入4006.8万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091116152097895db5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091116152097895db5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1617","BK1141","02228"],"gpt_icon":0},{"id":"2566598439","title":"70家创新药上市公司 3家靠自身造血盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2566598439","media":"经济观察网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566598439?lang=zh_cn&edition=fundamental","pubTime":"2025-09-11 13:47","pubTimestamp":1757569620,"startTime":"0","endTime":"0","summary":"近八成企业仍在亏损在70家港股18A与科创板创新药企业中，有55家仍在亏损，占比79%。通过销售创新药盈利，仍是对企业自身造血能力的考验。即便是康方生物这种明星公司，目前也未能依靠创新药销售盈利。除去两地上市的百济神州，共有15家创新药企实现盈利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509111348509788c7e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509111348509788c7e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1880383366.USD","00512","06160","03692","BK1141","LU0039217434.USD","SG9999002562.SGD","LU0348825331.USD","BK1161","LU0708995583.HKD","LU0326950275.SGD","LU0588546209.SGD","01548","SG9999002463.SGD","LU0140636845.USD","LU0456827905.SGD","LU1242518857.USD","LU0348735423.USD","03347","LU0052750758.USD","LU1794554557.SGD","06185","BK1610","LU0043850808.USD","LU1720050803.USD","02196","IE00B0JY6N72.USD","LU0417516902.SGD","09926","LU0359201612.USD","LU0516423174.USD","LU2039709279.SGD","01530","LU1242518931.SGD","BK1521","00867","09969","01952","LU0823426308.USD","02228","BK1589","LU0516422952.EUR","LU1688375341.USD","LU0572944931.SGD","06821","LU0359202008.SGD","00460","LU0417516738.SGD","LU0320764599.SGD","LU0979878070.USD","LU0181495838.USD","LU0051755006.USD","LU0456846285.SGD","LU0516422440.USD","BK1574","LU0819121731.USD","BK1576","02268","06978","00013","06127","01877","LU0307460666.USD","LU0516423091.SGD","02269","LU0823426480.USD","LU0327786744.USD","01513","LU0516422366.SGD","LU0856984785.SGD","01093","06955","01801"],"gpt_icon":1},{"id":"2566405930","title":"国家卫健委：我国跃居全球新药研发第二位","url":"https://stock-news.laohu8.com/highlight/detail?id=2566405930","media":"央视新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566405930?lang=zh_cn&edition=fundamental","pubTime":"2025-09-11 11:16","pubTimestamp":1757560562,"startTime":"0","endTime":"0","summary":"今天上午，国新办举行“高质量完成‘十四五’规划”系列主题新闻发布会，介绍“十四五”时期卫生健康工作发展成就。据介绍，我国在研新药数量占全球数量的比例超过20%，跃居全球新药研发第二位，舒格利单抗、恩沙替尼、谷美替尼等多款国产创新药陆续获批上市，填补了相应领域国产创新药的空白。我国自主研发的抗肿瘤药品泽布替尼已在多个国家获批上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509111115279788448d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509111115279788448d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","01513","03347","00867","02268","00460","BK1583","02228","01530","02269","06127","01801","BK1593","01548","BK1161","00512","00013","01952","01877","02196","01093"],"gpt_icon":0},{"id":"2566934561","title":"川普制裁中国创新药？别被纽约时报的“小作文”忽悠了","url":"https://stock-news.laohu8.com/highlight/detail?id=2566934561","media":"越学习越贫穷","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566934561?lang=zh_cn&edition=fundamental","pubTime":"2025-09-11 09:27","pubTimestamp":1757554059,"startTime":"0","endTime":"0","summary":"如何看待这篇川普要制裁中国创新药的文章-中国创新药是不是不行了，以后不能BD出去，股价岂不是会暴跌？在上次川普威胁要降药价后，就一堆人担心创新药不行了。互相尊重IP，是现代商业的基石，美国药企之所以会竭尽所能维护从中国创新药BD，也有这方面的考虑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250911092426a71c0185&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250911092426a71c0185&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09995","01952","00013","02268","06185","01513","03692","06955","00460","03347","09969","BK4532","NYT","02228","01530","01548","02196","06821","00867","06160","00512","06127","BK4111","01877","02269","03759","01093","09926"],"gpt_icon":0},{"id":"2566939941","title":"海外云厂商指引爆表！美若降息港股反弹程度如何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2566939941","media":"汇添富基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566939941?lang=zh_cn&edition=fundamental","pubTime":"2025-09-11 08:35","pubTimestamp":1757550905,"startTime":"0","endTime":"0","summary":"消息面上，海外云厂商的业绩指引爆表。这表明港股对全球流动性改善、美元走弱及风险偏好修复具备同步响应能力。美降息将利于港股市场。标的指数并不能完全代表整个股票市场。恒生系列指数由恒生资讯服务有限公司全权拥有，并已授权恒生指数有限公司发布及编制。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250911083113a71c00b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250911083113a71c00b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00968","01797","02556","00020","01099","TECH","01735","09863","03888","HSTECH","01415","02587","02269","BK1593","00981","09988","02228","00285","01357","02015","00522","BK1583","01024","01211","09660","00241","02357","03896","00917","01548","00300","09926","BK1161","06088","09880","09626","01810","00992","01347","00780","03690","00175","HSCEI","06690","01530","02577","00853"],"gpt_icon":1},{"id":"2566678767","title":"创新药中场复盘：泡沫挤压后的新起点","url":"https://stock-news.laohu8.com/highlight/detail?id=2566678767","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566678767?lang=zh_cn&edition=fundamental","pubTime":"2025-09-10 15:08","pubTimestamp":1757488085,"startTime":"0","endTime":"0","summary":"在刚刚落幕的 WCLC，中国创新药企集中展示最新成果。随着二级市场回暖、业绩高增长与出海加速，泡沫挤压之后的创新药，正以临床价值和商业成果为双翼，迎来一个更理性、更健康、也更值得期待的新起点。参考资料1.wind，万联证券研究所2.各公司官网原文标题 : 创新药中场复盘：泡沫挤压后的新起点","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509101509049784db77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509101509049784db77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02162","BK1161","01093","01276","BK1574","09926","03692","01801","09995","06978","02228","01530","06160","SBHMY","01177","02269","02157","BK1141","BK1617"],"gpt_icon":1},{"id":"2566048926","title":"晶泰控股(2228.HK)：AI+人工智能自主实验平台驱动药物及材料研发 商业化加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2566048926","media":"招商证券","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566048926?lang=zh_cn&edition=fundamental","pubTime":"2025-09-10 00:00","pubTimestamp":1757433600,"startTime":"0","endTime":"0","summary":"晶泰以量子物理为基础，融合人工智能与机器人自动化技术，早期即着手数据积累，构建多模态AI 模型体系，覆盖药物发现核心环节。AI 制药商业化逐步落地。3）领先的机器人实验室：晶泰拥有200+研发机器人工站，5000m2+自有自动化实验室，以及先进的AI Agent 系统，为物质研发提供全链路保障。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091021013295215376&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091021013295215376&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141","BK1617"],"gpt_icon":1},{"id":"1162905053","title":"晶泰控股AI药物发现合作达成重要里程碑：Pharmaengine新型Prmt5抑制剂Pep08获得临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1162905053","media":"美股速递","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162905053?lang=zh_cn&edition=fundamental","pubTime":"2025-09-09 20:41","pubTimestamp":1757421677,"startTime":"0","endTime":"0","summary":"晶泰控股AI药物发现合作项目取得重要进展，合作伙伴Pharmaengine开发的新型Prmt5抑制剂Pep08成功获得临床试验批准，标志着该合作项目达成重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1617","02228"],"gpt_icon":0},{"id":"2566651673","title":"晶泰控股等在上海新设生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2566651673","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566651673?lang=zh_cn&edition=fundamental","pubTime":"2025-09-09 09:24","pubTimestamp":1757381083,"startTime":"0","endTime":"0","summary":"人民财讯9月9日电，企查查APP显示，近日，艾玮泰（上海）生物科技有限公司成立，注册资本1000万元，经营范围包含：药物检测仪器销售；制药专用设备制造；医用包装材料制造；包装材料及制品销售等。企查查股权穿透显示，该公司由晶泰控股等共同持股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509093508383869.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","BK1617","02228"],"gpt_icon":0},{"id":"2565089502","title":"每日卖空追踪 | 晶泰控股 09月08日卖空量成交591.9万股，卖空比例为3.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565089502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565089502?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 16:30","pubTimestamp":1757320229,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间09月08日，涨0.28%，卖空量成交591.9万股%，较上一交易日减少4.59%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908173916a71634c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908173916a71634c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1617","BK1141"],"gpt_icon":0},{"id":"2565576164","title":"晶泰科技(02228)助力智擎生技新一代“合成致死”新药获临床实验审批 AI制药再迎里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=2565576164","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565576164?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 09:20","pubTimestamp":1757294413,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，晶泰科技今日宣布，由其助力智擎生技制药发现的新一代PRMT5抑制剂PEP08已达成重要临床研发里程碑。基于此进展，晶泰科技确认获得该项目的里程碑付款。PEP08顺利获得两地监管机构的临床试验许可并达成里程碑付款，是晶泰科技与智擎生技合作取得的重要阶段性成果，再一次验证了晶泰科技平台高效赋能药物创新的交付能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1342422.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02228","01477","BK1141","BK1617","BK1191"],"gpt_icon":1},{"id":"2565523226","title":"医药生物行业跟踪周报：政策支持与技术迸发叠加 看好脑机接口产业链发展 建议关注诚益通、三博脑科等","url":"https://stock-news.laohu8.com/highlight/detail?id=2565523226","media":"东吴证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565523226?lang=zh_cn&edition=fundamental","pubTime":"2025-09-07 00:00","pubTimestamp":1757174400,"startTime":"0","endTime":"0","summary":"政策支持明确，技术突破显著，应用场景清晰，看好脑机接口产业链发展：脑机接口技术当前已经成为全球各国科技竞争的战略高地之一。2025 年我国成功开展首例侵入式脑机接口的前瞻性临床试验，诚益通等企业在侵入式电极方面也有所布局；翔宇医疗已开发11 款非侵入式脑机接口产品等。建议关注国内在脑机接口领域布局企业如：诚益通、三博脑科、翔宇医疗、创新医疗等。博瑞医药自主研发的1 类创新药BGM1812 注射液1 期临床申请已获受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250907194121a4b93020&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250907194121a4b93020&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","01530","01276","02228","BK1593","02359"],"gpt_icon":1},{"id":"1199659528","title":"异动解读 | AI药物研发龙头晶泰控股盘中大涨8.09%，南向资金连续7日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=1199659528","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199659528?lang=zh_cn&edition=fundamental","pubTime":"2025-09-05 11:22","pubTimestamp":1757042568,"startTime":"0","endTime":"0","summary":"周五盘中，港股生物医药板块AI药物研发龙头晶泰控股股价大涨8.09%，引起市场广泛关注。首先，晶泰控股上半年业绩亮眼。据报道，9月4日南向资金增持晶泰控股2806.30万股，这已经是连续第7个交易日增持。截至9月4日收盘，港股通共持有晶泰控股175088.99万股，占流通股43.59%。随着生物医药行业创新步伐加快，AI技术在药物研发中的应用日益广泛，晶泰控股有望继续受益于行业发展趋势，保持增长势头。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"gpt_icon":1},{"id":"2564305853","title":"晶泰科技到广药集团调研交流，共商合作新机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2564305853","media":"白云山官微","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564305853?lang=zh_cn&edition=fundamental","pubTime":"2025-09-04 22:20","pubTimestamp":1756995600,"startTime":"0","endTime":"0","summary":"9月3日，晶泰科技联合创始人、首席执行官马健一行到访广药集团。陈杰辉对晶泰科技的分享表示感谢，并介绍了广药集团的业务板块、发展方向和科研创新情况。晶泰科技作为一家优秀的智能化、自动化驱动的药物研发科技公司，双方可进一步加强对接沟通和协商，围绕产业重点领域关键方向构建合作机制，开启互利共赢、赋能创新的合作新局面。广药集团将积极利用AI科技赋能创新研发，以新质生产力助力生物医药产业高质量发展。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2025-09-04/doc-infpkapc8400176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02228","BK1141","BK1617","162414"],"gpt_icon":1},{"id":"2564832072","title":"晶泰控股完成配售2.86亿股  净筹26.3亿港元加速业务扩张与研发投入","url":"https://stock-news.laohu8.com/highlight/detail?id=2564832072","media":"格隆汇资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564832072?lang=zh_cn&edition=fundamental","pubTime":"2025-09-04 17:35","pubTimestamp":1756978554,"startTime":"0","endTime":"0","summary":"格隆汇9月4日丨晶泰控股宣布，配售协议所载全部条件均获达成，配售于2025年9月4日完成。根据配售协议的条款及条件，配售代理已按配售价每股配售股份9.28港元向不少于六名承配人成功配售合共2.86亿股新股份，占紧随配售完成后公司经扩大已发行股本约6.64%。配售所得款项总额约为26.533亿港元，而配售产生的所得款项净额约为26.298亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509041736539512fa8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509041736539512fa8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1617","BK1141","02228"],"gpt_icon":0},{"id":"2564320442","title":"晶泰控股(02228.HK)完成配售合共2.859亿股新股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2564320442","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564320442?lang=zh_cn&edition=fundamental","pubTime":"2025-09-04 17:33","pubTimestamp":1756978430,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","BK1617","02228"],"gpt_icon":0},{"id":"2564207633","title":"每日卖空追踪 | 晶泰控股 09月04日卖空量成交314.2万股，卖空比例为1.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564207633","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564207633?lang=zh_cn&edition=fundamental","pubTime":"2025-09-04 16:30","pubTimestamp":1756974628,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间09月04日，跌5.18%，卖空量成交314.2万股%，较上一交易日减少58.54%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904172337a4b398ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904172337a4b398ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1617","02228","BK1141"],"gpt_icon":0},{"id":"2564325152","title":"晶泰控股盘中异动 下午盘大幅下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564325152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564325152?lang=zh_cn&edition=fundamental","pubTime":"2025-09-04 14:27","pubTimestamp":1756967255,"startTime":"0","endTime":"0","summary":"2025年09月04日下午盘14时27分，晶泰控股股票出现异动，股价大幅下跌5.08%。晶泰控股股票所在的生物技术行业中，整体跌幅为5.83%。该信息摘要如下：晶泰控股盘中涨超8%，截至发稿，股价上涨7.37%，现报11.07港元，成交额19.87亿港元。晶泰控股近日发布中期业绩，收入5.17亿元人民币，同比增加403.83%；股东应占溢利8279.5万元，上年同期股东应占亏损12.37亿元，为集团首次实现半年盈利。此外，8月29日，晶泰控股宣布拟通过配售代理配售最多约2.86亿股配售股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509041427359512a025&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509041427359512a025&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141","BK1617"],"gpt_icon":1},{"id":"2564331718","title":"医药行业细分龙头+医药政策频出，该公司有望再爆发！","url":"https://stock-news.laohu8.com/highlight/detail?id=2564331718","media":"巨丰投顾","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564331718?lang=zh_cn&edition=fundamental","pubTime":"2025-09-04 06:28","pubTimestamp":1756938494,"startTime":"0","endTime":"0","summary":"今天带来一只医药行业细分龙头，一起看看背后的起爆逻辑。下游是流通与终端应用，药品经线下医院、药店，以及线上电商平台等渠道，抵达终端消费者。医药行业未来发展趋势在创新药领域，随着老龄化加深及疾病谱改变，对创新药需求激增。像人福医药，连续6年将医药工业10%以上营收投入研发，2025年上半年6款1类新药获批临床，未来创新药有望持续突破，引领行业发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904062914a4b2704f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904062914a4b2704f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","LU0359201885.HKD","LU0359202008.SGD","02196","01276","LU0359201612.USD","LU1023057109.AUD","LU2543165471.USD","BK1191","02228","09939","BK1574","BK1161"],"gpt_icon":1},{"id":"2564803692","title":"每日卖空追踪 | 晶泰控股 09月02日卖空量成交1132.8万股，卖空比例为6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564803692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564803692?lang=zh_cn&edition=fundamental","pubTime":"2025-09-02 16:30","pubTimestamp":1756801828,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间09月02日，跌1.5%，卖空量成交1132.8万股%，较上一交易日减少67.05%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902172303a4af5fb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902172303a4af5fb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1617","BK1141"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":199,"code":"91000000","status":"200"}]}}